🖼️00Read later0Read MoreCohance Lifesciences: Can a recovery justify its valuation?The Indian Express·Rahul Rao·16 days ago#2eZ6v03z#indianexpress#cohance#lifesciences#revenue#fell+3 more🧰Tag tools✨Add tagCohance Lifesciences business numbers have been hard to stomach. FY26 revenue fell 13% and adjusted EBITDA nearly halved. Q1 FY27 revenue fell 23%, adjusted EBITDA margin dropped to 2.2%, and the company reported a net loss of Rs 45 crore.… Read more15s
🖼️00Read later0Read MoreAlbumentations in Life Sciences: Who Actually Uses ItDEV Community·Vladimir Iglovikov·6 months ago#BRnKfPwr#lifesciences#academic#hugging#microscopy#life+5 more🧰Tag tools✨Add tagAlbumentations is shared image-augmentation infrastructure for life-sciences AI. It shows up in...15s
🖼️00Read later0Read MoreArtisan Global Opportunities Fund Q1 2026 Portfolio ActivitySeeking Alpha·Artisan Partners·7 months ago#cW4jihCd#source#chevron#alpha#quarter#edwards+7 more🧰Tag tools✨Add tagDuring the quarter, we initiated new positions in Edwards Lifesciences, Eli Lilly and Roblox.15s